News and Events
All Articles
Unlocking Pharmacy Value for Private Equity Firms
RxBenefits, Inc. Appoints Robert Gamble Chief Executive Officer
How To Break Through the Barriers Facing Biosimilars
The Cost Conundrum of GLP-1s and Their Impact on Pharmacy Spend
Pharmacy Times Part 2: What Went Wrong – How Formularies, Contracts, and Rebates Created a Headwind for Biosimilars
Chief Pharmacy Officer, Mark Campbell Featured in Pharmacy Times
Meet Our Experts: Annette Sanjines and Norm Puente
Wendy Barnes Featured in Pharmacy Times: How to Tame the Rising Cost of Medications
Mark Campbell Featured in BenefitsPro Article: Managing the Financial Side Effects of Specialty Drugs
Enjoy our latest blogs, white papers and news by signing up for our newsletter today!
